my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Algeta is a Norwegian therapeutics company focused on the development of alpha particle emitters as radiopharmaceuticals for the treatment of cancer. The Company is targeting metastatic and disseminated tumor types for which there is substantial unmet medical need. Its first product candidate Alph more
Ablynx and Algeta ASA announce a research collaboration to evaluate a novel Targeted Thorium Conjugate (TTC) based on combining Algeta’s proprietary thorium-227 alpha-pharmaceutical payload with Nanobodies® generated using Ablynx’s proprietary technology platform.Under the terms of the collaboration more
Algeta ASA celebrated the official opening of the offices and facilities of Algeta US in Cambridge, Massachusetts.In September 2009, Algeta signed an agreement with Bayer for the development and commercialization of Alpharadin. Under the terms of the agreement, Bayer will develop, apply for global h more
Cobra Biologics Ltd and Algeta ASA announced a new contract manufacturing partnership for Algeta’s fourth Targeted Thorium Conjugate (TTC) program. The program will focus on the development of an undisclosed monoclonal antibody, which is highly selective for a validated cell surface target on hemato more
Introduction GlobalData, the industry analysis specialist, has released its new report, “Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Bone Metastases Therapeutics market. The report iden more
PCI Biotech AS (PCI Biotech) is principally engaged in the development and commercialization of photochemical drug delivery technology for use in cancer therapy and other diseases. The technology is used in the areas such as gene therapy, protein therapy, oligonucleotide therapy, chemotherapy and na more
Nattopharma ASA (Nattopharma) is a publicly held company focusing primarily on research, developing and selling of vitamin K2. Its products are marketed under the trademark MenaQ7, the natural vitamin K2 derived from natto. MenaQ7 is available in two forms mainly powder and oil solution. It is empl more
Home About Us Overview Management Team Board of Directors Scientific Advisory Board Assay Development, Biochem Technology Activators of innate immunity Phosphate Protected Nucleotide Prodrugs Hyperglycosylated Type I Interferons News Room Press Releases Scientific Publications Careers Contact Contac more
Home About us Pronova BioPharma in brief Production facilities History Our business concept Vision, values and strategy Ethical guidlines Health, safety and environment Human resources Management team Board of directors Product Omacor/Lovaza Production process Market Distribution and partners Resear more
Sitemap | Search | Glossary | Terms | Contact | Deutsch Company Diagnostic Products Biomarker Services Science & Technology Investor Relations Newsroom Downloads Career Imprint Management Corporate Strategy Supervisory Board Scientific Advisory Board Medical Advisory Board Network & Partne more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
